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We have developed an exon-trapping system with a newly constructed trapping vector containing multiple cloning sites (designated pEXT2). The 
system revealed high sensitivity for trapping a control exon from several hundred kbp of DNA. We have apphed the system to the cosmtd clones 
located on human chromosome 21pll&q21. and identified two fragments highly homologous to neurofibromatosts 1 (NFl) gene and a clearly 
transcribed fragment hybridized with -1.6 kb RNA from human brain and human glioblastoma Al72 cell. 
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1. INTRODUCTION 
Recent advances in human genetic and physical map- 
ping enable us to identify genes responsible for human 
disease by positional cloning [l]. In this strategy, once 
a location of the responsible gene is determined by ge- 
netic linkage analysis, it is possible to approach the gene 
by isolating candidate genes from corresponding 
genome segment. Several methods are available for the 
isolation of genes from specified genomic segments, 
which involve search for interspecies cross-hybridiza- 
tion (zoo blot) [2], sequence-based exon prediction [3], 
CpG islands [4], promoters [5] and enhancers [5, 61. 
However, these methods cannot provide transcribed se- 
quences directly. 
An exon-trapping system has been recently devel- 
oped, which directly provides possible exons by utilizing 
RNA splicing reaction carried out in mammalian cul- 
tured cells [7-lo]. Selection of a trapping cassette in the 
exon-trapping vector is a crucial matter for the sensitiv- 
ity and specificity of the system. Several genes were used 
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as trapping cassettes in the previously reported system 
[7-lo], whereas the efficiency of these trapping cassettes 
in their systems seemed to be variable. 
Here, we report the realisation of our exon-trapping 
system using a newly constructed trapping vector, in 
which the rat a2 macroglobulin gene was used as a 
trapping cassette and multiple cloning sites were con- 
structed (pEXT2). The system revealed high sensitivity 
for trapping a control exon from several hundred kbp 
of DNA. Using this system, we have identified two 
fragments highly homologous to the neurofibromatosis 
1 (NFl) gene and a discretely transcribed fragment 
from the cosmid clones located on human chromosome 
21pl l-q21. 
2. MATERIALS AND METHODS 
2.1. Vimor construction 
The exon trapping vector pEXT2 was constructed as follows. A -2.4 
kbp of PruII fragment from the plasmid pUC13 was hgated with a 
BgflI hnker to yield pUC-BgnI. The plasmid pSV2A/L-A.45 [l I] was 
cut with XbuI and self-ligated to yield pSV2A/AL. After removing the 
Hind111 sttes in pSV2A/AL by blunt-end cloning, the-l .3 kbp ofBamH1 
fragment containing an SV40 early promoter, a remaimng -70 bp of the 
luciferase gene and a SV40 poly-adenylation stgnal. was cut from the 
plasmid and inserted into the &AI site of pUC-&$I1 (designated 
pucsvz). 
A 2.3 kbp of EcoRI-SfuI fragment containing exon 1, intron 1 and 
part of exon 2 of the rat a2 macroglobuhn gene (position 4369- 6619) 
[12], was inserted into the EcoRI and filled-m Ban1H1 sites of pUC13. 
The remaming BumHI site in the plasmid was removed by blunt-end 
clonmg. and the BgfiI site (position 4541) [12] was also removed 
by insertion of an XbaI linker. The resultant XhaI fragment was 
cut from the plasmtd and inserted into the XbaI sate of pUCSV2 
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m the sense ortentatton to the SV40 early promoter (designated 
pEXT1). Finally, pEXT1 was cut with EcoRV and Pstl. and ligated 
with pre-annealed ohgonucleottdes, S’-ATCAAGCTTGGATCCG- 
GAATTCACGGCCGCTGCA-3’ and 5’-GCGGCCGTGAATTC- 
CGGATCCAAGCTTGAT-3’. to yield pEXT2 with multiple cloning 
sites. 
The PCR primers used in the present study were as follows. F3. 
5’-TTCCGGTACTGTTGGTAAAAT-3’, R2. S’-TCTGTAGGTA- 
GTTTGTCCAATTAT-3’; MacF. S-GCCTCAGCTCCACAAAAA- 
CC-3’; MacR, 5’-GAGGGAACCATCACCATGTAG-3’; T7-MacR, 
5’- CGTAATACGACTCACTATAGGGAGGGAACCATCACCAT- 
GTAGA-3’. All reactions were performed with 200 nM of prim- 
ers and 2.5 U of Tuq DNA polymerase m Tuq polymerase buffer 
consisting of 10 mM Tris-HCI pH 8.3, 50 mM KCI. 1.5 mM MgCl,, 
0.001% Gelatm and 200 PM dNTPs. The thermal cycle conditions for 
PCR amplification were 94°C for 1 mm. 55°C for 2 min. 72°C for 3 
min. 
A cosmid hbrary was constructed using Lortst2 [13] and the ham- 
ster-human hybrid cell line 2Fur which contains human chromosome 
21 long arm as sole human component (21~1 I-qter) [l-l] The library 
was screened with human repetitive elements Alar and/or Ll, resulting 
m the isolation of 33 clones. Each cosmid clone was then wholly 
labeled with [a-“P]dCTP by random oligonucleotide primmg, and 
used as a probe. Ftve micrograms of partially sheared genomrc DNA 
from cultured cell hnes, were alkali-denatured and dot-blotted onto 
a Hybond-N membrane (Amersham). Hybrtdizatron was carried out 
by the method of Corbo et al. [ 151. except that the pre-annealmg time 
of DNA probes with human placental DNA was 2 h. The cell hnes 
used for dot-blot analysrs and their retained region of human chromo- 
some 21 were as follows. WAV-17 (whole human chromosome 21 as 
sole human component)[l6]; C2-TlO (21p12-qter)[l7]; A24 (?lpter- 
p12)[17]: 1881c-13b (21q22_qter)[l8]. Human ghoblastoma Al72 and 
mouse fibroblast A9 were also used as controls. WAV-17, C2-TlO, 
A24, Al 72 and A9 were purchased from ATCC. and ‘Fur andlSSlc- 
13b were a gift from Dr. David Patterson 
2.4. Cell Cultrrre. DNA trwujertton und RN.4 mlatron 
COS-7 cells were cultured m Dulbecco’s modified Eagle’s medmm 
containing 10% heat-mactrvated fetal calfserum. 4 5% glucose and 100 
&,/ml kanamycm. DNA transfection was performed by the method 
of Buckler et al. [S] with mmor modifications. COS-7 cells grown to 
8&95% confluency, were harvested and \vashed once with phosphate- 
buffered-saline containing no divalent cations (PBS(-)). The cells 
(4 x 10’) were resuspended m cold PBS(-) (0 7 ml), put mto a pre- 
cooled electroporatron cuvette (Bio-Rad) and combmed with plasmtd 
DNA (10 pg in 0.1 ml of PBS(-)). After IO min of incubation on ice. 
the cells were gently resuspended, electroporated with a Bio-Rad Gene 
Pulser (3 kV/cm; 35 pF; 200 Q). and placed on ice for 10 min. The 
transformed cells were plated on a tissue culture dish (90 mm) contam- 
ing 10 ml of prewarmed culture medium. After 48-72 h of transfection, 
the cells grown on the ttssue culture dish were rinsed with PBS(-). and 
harvested by incubatton wtth IO ml of 0.05% (w/v) EDTA m PBS(-) 
at 37°C for 10 min Cytoplasmrc RNA was Isolated by a conventional 
method [19]. and poly(A)’ RNA was prepared by using a Magna 
PolyAAA’ RNA Isolation Ktt (Promega). 
2.5 Re~ersr-trcr?wcrtptron f RTJ-PCR 
Cytoplasmic poly(A)’ RNA (0.3-0.6 ,ug) in the Taq DNA polym- 
erase buffer was denatured at 65°C for 10 min. One mM of dNTPs. 
5pM of random hexanucleotides, 40 U of RNasin (Promega). and 200 
U of Superscript reverse transcriptase (BRL) were added to the reac- 
tion mixture, and then mcubated at 42°C for 90 min (final vol. 20 ~1). 
After the reactton, RNaseH (1 U) was added and incubated again at 
37°C for 10 min. Half of the RT reaction was directly subjected to 
primary PCR amphfication usmg the forward primer F3 and the 
reverse primer R2 for 30 cycles. The 0.3-0.9 kbp PCR products. 
size-fracttonated by electrophoresis through a 1% agarose gel, were 
eluted and filtrated through a 0.45 pm membrane filter cartridge 
(UFC33OHV. Miligen). The filtrate (l/lOOOth) was then subjected to 
secondary PCR amplification usmg the forward primer MacF and the 
reverse primer MacR for 35 cycles. The secondary PCR products were 
electrophoresed agam through 333.5% agarose gel. The 50-600 bp 
fragments were purified and cloned into pBluescript II (Stratagene) by 
the T-Vector method [20]. 
2.6. DNA seqtrenctng 
Trapped fragments were sequenced on the ALF DNA sequencer 
with an AutoRead DNA sequencmg kit (Pharmacia). The cycle se- 
quencing was carried out with dsDNA Cycle Sequencing System 
(BRL) 
2 7 RNA blot ltybridcutiott 
Total RNA was extracted by the method of Chomoczynski and 
Sacchi [21]. and poly(A)’ RNA was isolated by Oligotex-dT30 
(Roche). RNA was denatured by formaldehyde and electrophoresed 
through formaldehyde/l% agarose gel A Hybond-N nylon membrane 
(Amersham) was used for blotting. Trapped fragments cloned into 
pBluescrrpt II were PCR amplified usmg the forward primer MacF 
and the reverse primer T7-MacR whtch the latter contams the T7 
promoter sequence prior to the MacR primer [22]. with the conditions 
described above except for the anneahng temperature at 60°C. Rrbo- 
probes were synthesized from the PCR products usmg [a-“P]UTP and 
T7 RNA polymerase Hybridization was carried out by the manufac- 
ture’s recommended method (Stratagene) except for addmg yeast 
tRNA (200 pg/ml) m the hybridization solution to suppress non- 
specific signals. 
3. RESULTS 
3.1. Eson trapping qstem 
The final construct of the exon-trapping vector 
pEXT2 is shown in Fig. 1. The trapping cassette in 
pEXT2 consists of exon 1, intron 1 and part of exon 2 
of the rat a3 macroglobulin gene, which is under the 
control of SV40 early promoter (Fig. 1A). The multiple 
A 
u2Mac 
SV40 early promoter exonl 
. 
sspllce s,te 
s Mi?iF 
* 
Transcription 
polyA stgnal 
B 
5’.GATATCAAGCTTGGATCCGGAATTCACGGCCGCTGCAG-3, 
3’.CTATAGTTCGAACCTAGGCCTTAAGTGCCGGCGACGTE’ 
_uu_u u_ 
EcoRV bhndlll BarnHI EcoRl Eag I PSI I 
Acclll 
Fig. 1. Schematic representation of the exon-trapping vector pEXT2. 
(A) Structure of the trapping vector. The SV40 early promoter, and 
exon 1 and 2 of the rat a2 macroglobuhn gene are described above 
each box. The horrzontal line between exon 1 and 2 represents the 
intron sequence. A solid box in the mtron means multiple cloning sites, 
Small arrows indicate primers and a large arrow Indicates direction 
of the transcriptton. (B) Nucleotide sequence of multrple cloning sites. 
The sequence is described m the same ortentatron to (A). Seven restrtc- 
tion enzyme sites umque m the plasmid pEXT2. are shown below the 
sequence. 
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Fig. 2. Analysis of the RT-PCR products by agarose gel electrophore- 
ses. (A) The secondary PCR products were electrophoresed through 
3.5 % agarose gel. Lane 1 shows 200 ng of Hue111 dlgested $-X174 
DNA marker. Lanes 2 to 5 show the PCR products derived from the 
plasmids described below. Lane 2, pEXT2 with no insert; lane 3, 
pEXTZ/APPexonl7S; lane 4, pEXT2/APPexon 17AS. lane 5, plasmid 
mixture containing 150 independent clones and pEXT21APPexonl7S 
in the molar ratio 15O:l (see section 3). (B) An example of the secon- 
dery PCR products derived from the cosmid clone 379 (lane 2) and 
478 (lane 3). Lane 1 shows 200 ng of Hue111 digested @-X174 DNA 
marker. 
cloning sites consisting of seven unique restriction en- 
zyme sites were constructed in intron 1 for inserting 
various DNA fragments (Fig. 1B). When pEXT2 is 
transfected into COS-7 cells, the trapping cassette is 
proposed to be transcribed and then spliced to produce 
a mature cytoplasmic poly(A)’ RNA. If an appropriate 
fragment containing the entire exon and the flanking 
intron, is inserted into the cloning sites of pEXT2 in the 
sense orientation to the transcription, the exon is ex- 
pected to be trapped between the exon 1 and 2 of trap- 
ping cassette in the mature cytoplasmic poly(A)’ RNA. 
The trapped exon can be easily identified by reverse- 
transcription (RT)-PCR, since the RT-PCR product 
containing the trapped exon is longer than the non- 
trapped RT-PCR product. 
To examine whether an appropriate exon is trapped 
ideally, a 1.2 kbp genomic fragment encompassing the 
exon 17 of amyloid /3 protein precursor (APP) gene [23] 
was inserted into pEXT2 in the sense and anti-sense 
orientations (designated pEXT2/APPexon17S and 
pEXT2/APPexon17AS, respectively). The plasmids 
were independently transfected into COS-7 cells, and 
cytoplasmic poly(A)’ RNA, extracted from the cells 
after 2 days of incubation, was amplified by RT-PCR 
(see section 2). Fig. 2A shows an analysis of the second- 
ary PCR products. The expected band of 191 bp was 
observed only when the genomic fragment was inserted 
in the sense orientation (lane 3). The corresponding 
band was sufficiently detected even after the primary 
PCR was carried out (data not shown). We sequenced 
the 191 bp band directly by cycle sequencing, and con- 
firmed that the exon 17 of APP gene was precisely 
trapped between the exon 1 and 2 of the rat c~2 macro- 
glbulin gene (data not shown). On the other hand, a 44 
bp band corresponding to non-trapped fragment was 
observed in the lanes of pEXT2 with no insert and 
pEXT2/APPexon17AS (lanes 2 and 4). 
In the next step. we evaluated the sensitivity of the 
system. The 0.6-6 kbp of HindIII-digested inserted 
DNA, derived from the human chromosome 21 library 
(LL21N02. ATCC) [24], was inserted into the Hind111 
site of pEXT2. The plasmid DNA was prepared from 
150 independent colonies and mixed with pEXT2/AP- 
Pexonl7S in the molar ratio 150 : 1. The mixed plasmid 
DNA was subjected to exon-trapping and the RT-PCR 
products were analyzed by agarose gel electrophoresis. 
Two trapped bands strongly stained were observed 
(Fig. 2A, lane 5). They were cloned into pBluescript II 
and analyzed by sequencing. We confirmed that the 
upper band comparable to the band of lane 3, was, as 
expected, for the exon 17 of APP gene. On the other 
hand, the lower band, unexpectedly trapped, was for 
exon 4 of superoxide dismutase 1 (SODI) gene which 
is located on human chromosome 21q22.1 [25] (data not 
shown). The results indicate that both the control exon 
and the exon 4 of the SOD1 gene were successfully 
trapped from 150 independent clones with a mean 4 kbp 
inserted fragment, thus several hundred kbp of DNA 
can be assayed at one time. 
3.2. Application of pEXT2 exon-trapping system to 
human chromosome 21pl l-q21 
We have applied the system to the proximal region of 
the human chromosome 21 long arm, because few genes 
have been identified within the region [27], whereas 
some early-onset familiar Alzheimer’s disease has 
shown a linkage to chromosome 21 DNA markers lo- 
cated on the region [26]. Thirty-three human chromo- 
some 21 cosmid clones, obtained from a cosmid library 
constructed from the hamster-human hybrid cell line 
2Fur which contains the human chromosome 21 long 
arm as sole human component (21pll_qter)[14], were 
screened by dot-blot analysis using the genome DNA 
from several rodent-human hybrid cell lines (see section 
2). Twelve cosmid clones exhibited positive signals in 
WAV-17 and C2-TlO and negative signals in 1881c-13b, 
and therefore their locations were determined on 
21~1 l-q21 (data not shown). The selected clones were 
subjected to exon-trapping independently. The Sau3AI 
partially cut DNA fragments from each cosmid clone 
were inserted into the BamHI site of pEXT2. Plasmid 
DNA were prepared and transfected into COS-7 cells. 
The RT-PCR products were analyzed by agarose gel 
electrophoreses (Fig. 2B). The discrete bands were ob- 
tained from 6 of 12 cosmid clones and cloned into 
pBluescript II. 
3.3. Analyses of the trapped fragments 
Firstly we investigated the length and the existence of 
possible reading frames by sequencing all of the cloned 
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Table I 
Characterization of trapped fragments. Trapped fragments were 
cloned into pBluescript II. The name of each clone was determined by 
a combination of the original cosmid number and the followmg sub- 
number. N.D.. not determined. 
Clone 
Name 
244-20 
379-8 
379-10 
379-l I 
478-9 
478-26 
661-19 
1090-3 
1090-25 
1113-13 
1113-16 
Trapped Readmg DNA Sequence North- 
Fragment Frame Homology Search ern 
Size (bp) Analysis 
55 + 
106 + - 
155 + - 
138 + + (1.6kb) 
125 + _ 
173 + NF 1 homologue N D. 
41 + - 
138 - N.D. 
80 + NFl homologue N.D 
200 + _ 
95 + _ 
trapped fragments corresponding to the discrete bands 
(Table I). The length of eleven trapped fragments were 
41-200 bp and mean 119 bp. Ten of eleven trapped 
fragments had possible reading frames. A computer 
search for sequence homology in Genbank and EMBL 
data library by using the FASTA program [28] revealed 
that clone 478-26 and 1090-25, which were obtained 
from independent cosmid clones, had almost the same 
nucleotide sequences to the 5’-terminal side of neurofi- 
bromatosis 1 (NFl) gene (Fig. 3). In spite of several 
nucleotide differences, these two clones still had a read- 
ing frame without frameshifts. The other trapped frag- 
ments had no significant homology to the nucleotide 
sequences of the database. 
To investigate whether the trapped fragments with 
reading frames are expressed or not, RNA blot hybrid- 
ization was performed. The trapped fragments on 
pBluescript II were PCR-amplified with a set of prim- 
ers, MacF and T7-MacR, of which the latter contains 
the promoter sequence for T7 RNA polymerase prior 
to the MacR sequence. Riboprobes were synthesized 
from the PCR-amplified products and hybridized with 
poly(A)’ RNA derived from human brain and human 
glioblastoma A172. Clone 379-l 1 showed a discrete 
hybridization signal of -1.6 kb in both RNAs (Fig. 4). 
4. DISCUSSION 
In the present study, we firstly showed the realisation 
of an exon-trapping system with the newly constructed 
trapping vector pEXT2. We have selected the rat a2 
macroglobulin gene as a trapping cassette, because the 
consensus sequences for RNA splicing, which involve 
5’- and 3’-splice sites, a branch site and a pyrimidine 
tract, are sufficiently conserved in intron 1 of the gene. 
Furthermore, we have constructed multiple cloning 
sites in the intron to be able to conveniently insert DNA 
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fragments cut with several restriction enzymes. whereas 
most of the trapping vectors reported previously had 
only one cloning site [S-lo]. 
Using this vector. we showed that both exon 17 of the 
APP gene and exon 4 of the SOD1 gene were success- 
fully isolated from the plasmid mixture, and that thus 
several hundred kbp of DNA can be assayed at a time. 
However, when the PCR product obtained from the 
plasmid mixture was applied to an acrylamide gel, we 
also detected several weak additional bands. Sequence 
analysis for such weak bands showed that the bands 
were unexpectedly spliced products using a cryptic 
splice site -20 bp upstream from the multiple cloning sites 
(data not shown). Nonetheless. they did not seem very 
effective in our trapping system, since the unexpected 
cryptic splicing products represented only a very small 
portion of the PCR products. This may be explained by 
the fact that RNA processing using mutated splice sites 
comparable to the cryptic site is less efficient than that 
of normal splice sites [39]. Construction and evaluation 
of the exon-trapping vector from which such cryptic site 
is removed by site-directed mutagenesis, are in progress 
to further improve the system. 
We have applied the system to human chromosome 
2lplllq21. This region is estimated to be seven meg- 
1 20 
MaCF 
478-26 GCCTCAGCTCCACAARAA CCAnGTTGTTACTGGACAGTCTATGGAAAGCT 
..... .. : 
NFI. ~GTTATTTCTGG~CAGTCTACG~~C~ 
lose 1100 
40 60 80 
478-26 CTTGCTGGCiACGGAGGAAGTAGGCAGCT~AcACAAAGTTCTGcAATTG~ . . . . . . .._ .._.._.... 
NF1 ,,TGcTGGc,T~,,~,~,,~~~~~~~~G~~~GcTG~ATTG~ 
478-26 
NFl 
478-26 
NFl 
478-26 
B 
1090-25 
NFL 
1120 1140 1160 
100 120 
CTGTGCCAAACTGTGTAAAGCAAGTACTTACATCAACTGGGAAGATAACG 
:.:' . . . . . . . . . . . . .._.___._........ ::_::__.____ 
CTGTdT~~TdTdT~~CAI\GTACT~A~T~TTGGG~G~~~~T 
ll8b 1200 
140 160 174 
CTGTCATTT'iCCTACTTGTTCAGTCCATG&GGTTGATCTTAA&,ATCT . . . ,......._ .- .._..._. .._ . . . ..__..__._ 
CTGT~TTTTCCTACTTGTTCAGTCCATGGTGGTTGATCTTAAG 
1220 1240 125s 
Ma& 
ACATGGTGATGGTTCCCTC 
1 20 
MaCF 
GCCTCAGCTCCACAA?d.A CCL~CTCTGCTGGTTCTTCGTCAGTTAGATAGC 
:.'::'. .::::._ __,__ 
GCTCTGCTGGTTCTTCATCAGTTAGATAGC 
183s 1860 
40 60 80 
1090-25 ATTGATTTG~GGAATCCTGATGCTCCTGGiGAAAcATTTTGGGAGATTAi 
.._..._. ..::::::, ___:_ . . . . . . . . . . 
NF1 ATTGATTTGTGGAATCCTGATGCTCCTGTAGMiAcATTTTGGGAGATTAG 
I.**0 1900 1918 
MacR 
1090-25 AATCTACATGGTGATGGTTCCCTC 
Fig. 3. Sequence comparisons between two trapped fragments and the 
neurofibromatosls 1 (NFI) gene Two alignments between clone 47% 
26 and the NFI gene (A), and between clone 1090-25 and the NFl 
gene (B) are shown. Sequences from the trapping cassette are indicated 
by underlines. cDNA sequence of the NFl gene and its nucleotide 
number are from Marcheuk et al. [40]. 
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Fig. 4. Northen blot analysis of clone 379911. A riboprobe synthesized 
from clone 379-l’ were used for the hybridization. Lane 1, human 
glioblastoma Al 72 total RNA; lane 2. Al72 poly(A)’ RNA; lane 3, 
human bram poly(A)’ RNA. RNA used in each lane was 2 fig. Au- 
toradiography was performed at -70°C for 48 h with an intensifying 
screen. 
abase pair long by the contig map which was con- 
structed from yeast artificial chromosome clones cover- 
ing the entire human chromosome 21q [30]. It is highly 
conceivable that this region may not be gene-rich. since 
the distribution of known transcribed sequences on the 
chromosome 2 1 long arm are not uniform and few genes 
were identified within the proximal region of this chro- 
mosome [27]. Therefore, this region seems to be suitable 
for the approach by exon-trapping, the efficient method 
to identify transcripts within a large genomic region. 
Furthermore, genetic linkage studies have revealed that 
some families of early-onset Alzheimer’s disease co-seg- 
regated with chromosome 21 DNA markers located in 
this region [26]. 
Sequence analysis revealed two trapped fragments 
highly homologous to the NFl gene. The NFl gene is 
located on human chromosome 17 [31, 321, and until 
now, two NFl-related loci have been identified on chro- 
mosome 14 and 1.5 [33]. Therefore, the NFl-related 
locus identified on chromosome 21 in the present study 
may represent a pseudogene or a novel subtype of the 
NFl gene. In any case. genomic analysis around the two 
trapped fragments should be necessary. since each of 
them still possesses a reading frame in spite of several 
nucleotide differences from the NFl gene. 
RNA blot hybridization showed that the trapped 
fragment 379-l 1 was transcribed. Two transcribed 
clones, M21 [34] and JG90 [35], are involved in the 
region investigated in the present study [27]. The hy- 
bridization signal of -1.6 kb from clone 379911 seems to 
be smaller than the cDNA size of M21 or the transcrip- 
tion size of JG90 (1.8 kbp or 3.5 kb, respectively) [34, 
351. Since clone 379-l 1 also has no homology to any 
known sequences in the database, the clone is consid- 
ered to reflect an unknown gene. Its entire cDNA 
should be isolated for further characterization. 
Eight of eleven trapped fragments did not show any 
sequence homology to known sequences nor discrete 
expression in both brain and glioblastoma cell A172, 
although most of them possess reading frames and 
therefore were candidate exons. One of possible expla- 
nations is that corresponding unknown genes are not 
expressed in brain but in other tissues, and/or are tem- 
porarily expressed only at certain stages of develop- 
ment. Further analysis of such trapped fragments may 
be necessary to ascertain whether they reflect expressed 
genes or not. 
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